November 10, 2026 · European heart journal · DOI: 10.1093/eurheartj/ehag873

Sacubitril/valsartan for radiation-induced heart disease in children: preclinical and clinical findings.

Listen to this summary

Researchers asked whether early prophylaxis with sacubitril/valsartan can prevent radiation-induced heart disease in children, a population with scarce prospective data. Using a translational pipeline, they found that radiotherapy impaired cardiac function in pediatric cancer patients, that sacubitril/valsartan reduced fibrosis, diastolic dysfunction, and inflammation in a juvenile rat model, and that it improved left ventricular strain and aortic compliance in a small clinical cohort with a favorable safety profile over 12 months. Because the clinical cohort was small (15 per arm), these findings are preliminary and would need confirmation in larger randomized trials.

Li Zhao, Xia Guo, Yuanling Tang, Yimin Hua, Xiaoliang Liu, Fuping Yue, Xin Chen, Bowen Li, Xiaohui Dai, Chengqi Shen, Ju Gao, Kaiyu Zhou, Qianzi Tang, Chuan Wang

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play